Apollo Hospitals to Double AI Investment Over the Next 2 to 3 Years

Apollo Hospitals Enterprise is set to significantly expand its artificial intelligence (AI) capabilities over the next 2 to 3 years. The move comes after a strong first quarter, with profit growth driven by increased patient volumes.

Focus on Artificial Intelligence in Healthcare

Apollo Hospitals already employs AI tools for diagnostic purposes, including interpreting X-rays, scan reports and conducting endoscopic assessments, CEO Madhu Sasidhar stated to Reuters. These technologies assist in examining internal organs using advanced imaging, improving both accuracy and speed in diagnosis.

Innovative AI Projects Under Development

Recently, Apollo developed technology capable of analysing existing scan reports to predict the risk of liver fibrosis in the future. The company is also working on other next-generation AI tools to further enhance healthcare outcomes.

Strategic Collaborations for AI Advancement

In early 2025, Apollo partnered with Microsoft to create AI-based healthcare solutions. Several of these projects are currently in the testing phase, aimed at improving diagnosis, treatment planning and operational efficiency.

Expanding Hospital Network Alongside AI Growth

Apart from technological advancements, Apollo is increasing its hospital bed capacity to capture a larger market share. The company plans to add 4,370 beds over the next 3 to 4 years through acquisitions, new hospital projects and expansion of existing facilities, building on its current capacity of over 10,000 beds.

Read More: Jain Irrigation Systems Bags ₹135 Crore Order for Solar Pumps in Maharashtra! 

Industry-wide AI Adoption in Indian Healthcare

Other major Indian hospital chains, such as Manipal, are also investing in AI to improve patient care and streamline operations. This reflects a broader trend in the healthcare sector, where technology is being leveraged to enhance medical decision-making and efficiency.

Conclusion 

Apollo Hospitals’ planned AI expansion over the next 2 to 3 years underscores its commitment to advancing healthcare technology. This growth aims to enhance diagnostic precision and patient outcomes across its expanding network.

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in securities are subject to market risks. Read all related documents carefully before investing.